Clayton v. LombardiClayton v. Lombardi
Lead Opinion
Cecil Clayton moves for stay of his execution scheduled for March 17, 2015, at 6:00 p.m., pending full briefing and argument of his appeal from the district court’s dismissal of his complaint, brought under
I.
Clayton’s
II.
“[A] stay of execution is an equitable remedy.” Hill v. McDonough,
Clayton argues that the district court made clearly erroneous factual findings and misconstrued the law by not recognizing that his “lawsuit is based on the unique risks to him arising from his severe and undisputed brain damage.” Motion for Stay at 2. According to Clayton, his suit is distinguishable from prior lethal-injection actions because it “is based on the singular risks associated with Mr. Clayton’s severe brain damage — he is missing 20% of his frontal lobe — and physiological impact thereof.” Id. at 4. Clayton contends that he is likely to succeed on the merits of his appeal of the district court’s order dismissing his
Having reviewed Clayton’s
III.
Accordingly, we deny Clayton’s motion for stay of execution pending appeal.
Dissenting Opinion
dissenting.
I would grant a stay of execution to Cecil Clayton. I disagree with the majority that Zink v. Lombardi No. 14-2220,
Missouri death row inmate Cecil Clayton raises an as-applied challenge to Missouri’s current execution protocol and has filed a motion for stay of execution. Clayton argues, and the uncontested evidence shows, he is missing a large portion of his frontal lobe as a result of a sawmill accident. Clayton alleges that an attempted execution pursuant to Missouri’s current lethal injection protocol would lead to a gratuitous infliction of pain and suffering in violation of the Eighth Amendment. This is an as-applied Eighth Amendment challenge to Missouri’s current execution protocol.
The district court failed to acknowledge Clayton’s claim as an as-applied challenge and erroneously stated the issue was resolved in Zink, No. 14-2220,
Clayton’s unrebutted medical evidence demonstrates the requisite sufficient likelihood of unnecessary pain and suffering beyond the constitutionally permissible amount inherent in all executions. Clayton obtained and attached to his complaint a declaration from Dr. Mark J.S. Heath, an assistant professor of clinical anethesiology at Columbia University in New York. Dr. Heath states he is familiar with Missouri’s current execution protocol and Clayton’s brain damage. As relevant to this challenge, Dr. Heath stated as follows:
*903 If Missouri administers defective pentobarbital to Mr. Clayton there is an increased risk of a tortuous outcome. Because of the existing damage to his brain, he is particularly vulnerable and sensitive to the effects of any further brain damage. If defective pentobarbital fails to kill him but instead exposes him to a period of reduced or absent breathing, the resulting further damage to his brain could leave him in a profoundly neurologically damaged or destroyed state.
In response, Missouri alleges the current execution protocol, compounded pentobarbital, has yet to cause a painful or tortuous death. However, Missouri fails to put forth any evidence to show compounded pentobarbital can be safely administered to Clayton in light of his significant brain injury. Missouri merely notes the executions of healthy death row inmates have not appeared to be unconstitutionally painful. Missouri, however, has not put forward evidence showing the same compounded pentobarbital will be used for Clayton’s execution and Missouri has not contested Clayton’s description of his medical condition or Clayton’s particular risk factors. Missouri does not seriously contend Clayton is not at an increased risk of pain and suffering if an under-dose of pentobarbital is administered; rather, Missouri hopes the compounded pentobarbital used in Clayton’s execution will be correctly compounded, stored, and injected. Without the benefit of any evidence from Missouri, it is inappropriate to reject the uncontested evidence put forward by Clayton.
As I have noted in prior dissents, Missouri death row inmates have put forward substantial evidence demonstrating an unconstitutional risk of harm from compounded pentobarbital. See e.g., Zink, No. 14-2220,
As applied to Clayton, the concerns are far greater. Clayton has uncontested serious brain damage and is missing a large portion of his frontal lobe. Missouri does not contest that Clayton, because of this brain damage, is more susceptible to the effects of poorly compounded pentobarbital. And Missouri fails to put forth an expert to contravene the conclusion that “[t]he use of non-FDA-approved pentobarbital amplifies the risk of further injury to his already vulnerable and fragile brain.” Thus, I would stay Clayton’s execution and allow an evidentiary hearing to proceed below. If Missouri wishes to execute Clayton, they are required to do so in a way which does not create an unconstitutional risk of pain and suffering.